Femasys Inc. announced the achievement of CE mark certification for the FemBloc delivery system, marking it as the first regulatory approval in the world for a non-surgical permanent birth control ...
Femasys Inc. has announced the receipt of Conformité Européene (CE) mark certification for its FemBloc blended polymer component, marking the world's first regulatory approval for a non-surgical ...
ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY),, a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, ...
ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, ...
Hosted on MSN
What Are the Best Birth Control Options?
Birth Control Implants An implant is a thin rod thats inserted under the skin of your upper arm and releases progestin for up to five years, protecting you from pregnancy. It isn't permanent, and your ...
Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large, engaged patient ...
- Pivotal clinical trial to begin in the third quarter of 2023- ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results